Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Diagnostic power of rapid multifocal objective perimetry in Alzheimer’s
Author Affiliations & Notes
  • Ted Maddess
    Neuroscience, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia
  • Emilie Marie Francoise Rohan
    Neuroscience, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia
  • Mary Ann Kulh
    School of Medicine and Psychology, Australian National University, Canberra, Australian Capital Territory, Australia
  • Joshua van Kleef
    Neuroscience, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia
  • Bhim Bahadur Rai
    Neuroscience, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia
  • Corinne Carle
    Neuroscience, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia
  • Footnotes
    Commercial Relationships   Ted Maddess Konan Medical USA Inc, Code F (Financial Support), Konan Medical USA Inc, Code P (Patent), EyeCo Pty Ltd, Code S (non-remunerative); Emilie Rohan None; Mary Ann Kulh None; Joshua van Kleef Konan Medical USA Inc, Code P (Patent); Bhim Rai None; Corinne Carle Konan Medical USA Inc, Code P (Patent)
  • Footnotes
    Support  Biotechnology Bridge/MRFF BTBR100196
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 83. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ted Maddess, Emilie Marie Francoise Rohan, Mary Ann Kulh, Joshua van Kleef, Bhim Bahadur Rai, Corinne Carle; Diagnostic power of rapid multifocal objective perimetry in Alzheimer’s. Invest. Ophthalmol. Vis. Sci. 2024;65(7):83.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To examine the diagnostic power of novel measures obtained from three forms of pupil-mediated multifocal objective perimetry.

Methods : We examined 31 persons with early-stage Alzheimer’s (PwA, 19 males), and 36 control subjects (15 males). The ages of the PwA and control groups were well matched at 78.2 ± 6.50 years (mean ± SD) and 76.1 ± 5.81 years respectively. All tests were performed with an objectiveFIELD Analyser (OFA) by Konan Medical USA. Three test variants all presented 12 stimuli per eye respecting the horizontal and vertical meridians, extending to ± 30 degrees of the central visual field. One stimulus, W12, provided pseudo-randomly presented bright stimuli on a dim background (10 cd/m2) over 82 s. The other two differed in stimulus duration but both presented dark stimuli on a bright background (80 cd/m2). The durations were 82 and 360 s, hence the names W12D82 and W12D360. Diagnostic power was assessed by area under receiver operating characteristic plots (AUROC) and standardised effect size as measured by Hedge’s g. The input measure was the mean of the data for the worst performing 3 regions/eye. Separate analyses were done by splitting all subjects into males, and females, and by younger and older ages (> median age of 77). To cope with the unusual response waveform shapes produced by the dark stimuli we used the absolute value of deviations from the median delay for a given protocol relative to controls.

Results : The Table summarises the results. When split by ages (Table A) the best AUROC was for W12 and younger subjects (81.9 ± 4.08%, mean ± SD). For Hedge’s g old and young subjects were > 1.15 for W12D82. When split by sex the outcomes were similar. Overall, the longer duration of W12D360 appeared to offer no benefit relative to the shorter W12D82 test. We also examined combining the per region sensitivities and delays of W12 and W12D82. There was no advantage of combining the delays of the two tests, but combined sensitivities took AUROCs from 60.6 ± 6.41% to 80.1 ± 4.71% (p < 0.024).

Conclusions : Diagnostic performance for the shorter duration light and dark stimuli was reasonable. The fact that combined sensitivity increased diagnostic power suggests that they may characterise different aspects of Alzheimer’s. More work needs to be done to characterise the responses to dark stimuli.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

Summary of diagnostic power

Summary of diagnostic power

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×